HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of infliximab in the treatment for dermatomyositis with acute interstitial pneumonia: a study of fourteen cases and literature review.

Abstract
This retrospective study assessed the efficacy of infliximab therapy in 14 patients with dermatomyositis with acute interstitial pneumonia. Ten patients starting treatment at an early stage of the disease achieved satisfactory relief, while four patients treated at a late stage failed to respond to the treatment and died.
AuthorsDan Chen, Xiao-bing Wang, Yan Zhou, Xiao-chun Zhu
JournalRheumatology international (Rheumatol Int) Vol. 33 Issue 10 Pg. 2455-8 (Oct 2013) ISSN: 1437-160X [Electronic] Germany
PMID23715693 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Infliximab
Topics
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Dermatologic Agents (therapeutic use)
  • Dermatomyositis (complications, drug therapy)
  • Female
  • Humans
  • Infliximab
  • Lung Diseases, Interstitial (complications, drug therapy)
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: